☆ 4.6 Letter

Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Related references

Note: Only part of the references are listed.
Letter Medicine, General & Internal

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection
Letter Surgery

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely

Ayelet Grupper et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Add to Collection
Article Surgery

Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients

David Cucchiari et al.

Summary: The study on 148 kidney transplant recipients showed that the mRNA SARS-CoV-2 vaccine elicited either cellular or humoral response in 65.0% of the patients. Approximately 20.9% of patients were considered to have prior immunization against SARS-CoV-2, while 79.1% were deemed naïve to the virus.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Add to Collection
Letter Urology & Nephrology

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine

Ilies Benotmane et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.